Veterinary Medicines

Oridermyl

Authorised
  • Nystatin
  • Triamcinolone
  • Neomycin
  • Permethrin
Download as PDF

Product identification

Medicine name:
Oridermyl
Active substance:
  • Nystatin
  • Triamcinolone
  • Neomycin
  • Permethrin
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Nystatin
    100000.00
    international unit(s)
    /
    1.00
    gram(s)
  • Triamcinolone
    0.91
    milligram(s)
    /
    1.00
    gram(s)
  • Neomycin
    3500.00
    international unit(s)
    /
    1.00
    gram(s)
  • Permethrin
    10.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Ear ointment
Withdrawal period by route of administration:
  • Auricular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02DC
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Vetoquinol S.A.
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 808/09/07/1228
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 19/03/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."